title: Biomarkers: project update from the GRAPPA 2012 annual meeting.
abstract: For members of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), an important goal has been the identification of soluble biomarkers in psoriatic arthritis that might predict the development of radiographic progression. Work over the past year has resulted in approval of a draft protocol, and an announcement is forthcoming of the outcome of an assessment process for centers that applied to manage the project. GRAPPA is now ready to commence formal negotiations with potential funding partners and intends to initiate this project in the near future.
authors.affiliation: Department of Rheumatology, St. Vincent's University Hospital and Conway Institute for Biomolecular Research, University College, Dublin, Ireland. oliver.fitzgerald@ucd.ie
authors.forename: Oliver
authors.initials: O
authors.lastname: FitzGerald
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Mease
mesh_terms: D015535:Arthritis, Psoriatic / Q000175:diagnosis / Q000000981:diagnostic imaging* / Q000378:metabolism*; D015415:Biomarkers / Q000378:metabolism; D002097:C-Reactive Protein; D018450:Disease Progression; D006801:Humans; D019278:Matrix Metalloproteinase 3; D011237:Predictive Value of Tests; D011859:Radiography; D013548:Sweden
chemical_list: D015415:Biomarkers; D002097:C-Reactive Protein; D019278:Matrix Metalloproteinase 3
keywords: BIOMARKERS; CASPAR; PSORIATIC ARTHRITIS; PsA BioDam; RADIOGRAPHIC PROGRESSION